Vaccine Manufacturer Biological E. Limited Announced That the Subject Expert ... - Latest Tweet by IANS India
The latest Tweet by IANS India states, 'Vaccine manufacturer Biological E. Limited announced that the Subject Expert Committee of #CDSCO has approved the Phase 3 infants clinical trial data and recommended for manufacture of its 14-valent pediatric vaccine against Streptococcus pneumonia.'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)